TabletsClinical Overview
Clonazepam is a long-acting benzodiazepine with potent anticonvulsant, muscle-relaxant, and anxiolytic actions on the WHO Model List of Essential Medicines. It allosterically modulates GABAA receptors, increasing frequency of chloride channel opening and dampening epileptic foci in the cortex and limbic system. Indicated for panic disorder with or without agoraphobia, Lennox-Gastaut syndrome, myoclonic and akinetic seizures, and absence seizures refractory to succinimides.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally with water, or place mouth-dissolving tablet on tongue until dispersed. Can be taken with or without food. Divide daily dose into 2 to 3 equal doses, with the largest portion taken at bedtime. Taper dosage gradually when discontinuing.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Somnolence, ataxia, coordination disturbances, fatigue, dizziness, behavioral changes. Rare/Severe: Boxed warning: Respiratory depression, addiction and physical dependence, severe withdrawal seizures, status epilepticus upon abrupt discontinuation, and hepatotoxicity.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Black box warnings for addiction, abuse, misuse, and life-threatening interactions with opioids. Contraindicated in significant hepatic disease, acute narrow-angle glaucoma, and sleep apnea. Avoid alcohol.
Schedule H1 (Prescription Required - Habit Forming Warning)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Clonazepam Tablets 0.5 mg
Clonazepam is a long-acting benzodiazepine with potent anticonvulsant, muscle-relaxant, and anxiolytic actions on the WHO Model List of Essential Medicines. It allosterically modulates GABAA receptors, increasing frequency of chloride channel opening and dampening epileptic foci in the cortex and limbic system. Indicated for panic disorder with or without agoraphobia, Lennox-Gastaut syndrome, myoclonic and akinetic seizures, and absence seizures refractory to succinimides.
Escitalopram Oxelate 10mg + Clonazepam 0.5mg Tablets
Clonazepam and Escitalopram is a premier neuropsychiatric fixed-dose combination. Escitalopram, a high-affinity SSRI, selectively inhibits presynaptic serotonin reuptake to treat core depression and panic circuitry over time, while clonazepam, a long-acting benzodiazepine, delivers immediate allosteric enhancement of GABAA receptors, dampening initial SSRI-induced jitteriness, insomnia, and acute anxiety. Indicated for major depressive disorder with comorbid anxiety, panic disorder, and generalized anxiety disorder.
Clonazepam Tablets 1mg
Clonazepam is a long-acting benzodiazepine with potent anticonvulsant, muscle-relaxant, and anxiolytic actions on the WHO Model List of Essential Medicines. It allosterically modulates GABAA receptors, increasing frequency of chloride channel opening and dampening epileptic foci in the cortex and limbic system. Indicated for panic disorder with or without agoraphobia, Lennox-Gastaut syndrome, myoclonic and akinetic seizures, and absence seizures refractory to succinimides.
Paroxetine Prolonged Release Tablets 37.5mg
Paroxetine is a phenylpiperidine-derivative selective serotonin reuptake inhibitor (SSRI) with the highest affinity for SERT among all SSRIs. It also exhibits mild anticholinergic and nitric oxide synthase-inhibiting properties. Prolonged-release formulation ensures gradual drug release over 24 hours, mitigating peak-related gastrointestinal and sedative adverse effects. Indicated for major depressive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, and PTSD.